Drugs Medical Pharma

Jubilant Ingrevia raises capacity of acetic anhydride plant

HQ Team April 18, 2023: Jubilant Ingrevia, an Indian public-listed company, has commissioned its new global-scale acetic anhydride plant at its facility in.

Read More
Drugs Health Pharma

Prevention, preparedness, response to top G20 health group agenda

HQ Team April 17, 2023: Health emergencies, prevention, preparedness, and response, will top the agenda at the second Health Working Group meeting of G20 member.

Read More
Drugs Medical Pharma

India’s Astec LifeSciences to tap contract development market

HQ Team April 11, 2023: Astec LifeSciences, a subsidiary of Godrej Agrovet, opened its research and development centre in Rabale, Maharashtra, India, to.

Read More
Climate Health Pharma

India’s L&T bags hydrocarbon order worth up to $305 million 

HQ Team April 10, 2023: Larsen and Toubro, one of the world’s top construction companies, got an order worth up to INR 25.

Read More
Climate Health Pharma

India’s Tata Power secures $20.2 million NCD loan from ADB

HQ Team April 10, 2023: India’s Tata Power Company’s distribution arm has signed a pact with ADB for access to debt capital worth.

Read More
Health Medical Pharma

India tells states to ramp up COVID-19 emergency procedures 

 HQ Team April 8, 2023: India’s federal government has told state authorities to identify emergency COVID-19 hotspots and ramp up testing, vaccination, and.

Read More
Drugs Health Medical Pharma

Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout

H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.

Read More
Drugs Medical Pharma

Global Pharma recalls eye drops in US after ‘possible’ contamination

The CDC laboratory testing identified the presence of the outbreak strain in opened EzriCare bottles with different lot numbers collected from two states. 

Read More
Drugs Health Pharma

India fully exempts import tax for drugs treating rare diseases

India has granted a complete customs duty exemption for the personal use of medicines to treat rare diseases, including Merc & Co’s Keytruda.

Read More
Climate Health

Jain Irrigation merges with Israel’s Rivulis to cut consolidated debt

India's Jain Irrigation merged its international irrigation business with Israel-based Rivulis Pte. through a cash and stock transaction to reduce consolidated debt, according.

Read More
X